Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy L-654-040-antibacterial-agent

 Tricyclic macrolide antibacterial compounds
OF THE INVENTION Compounds of this invention, also referred to as "the compounds," comprise both ...


 Gene encoding MNR2 and uses thereof
OF THE INVENTION The following standard abbreviations are used throughout the specification to ...


 Polyene microlide pre-liposomal powders
OF THE PREFERRED EMBODIMENT A stable powder suitable for the direct preparation of liposome-...


 Process for stabilizing liposomes
We claim: 1. A process for stabilizing liposomes comprising: a) first forming liposomes by ...


 cDNA encoding human phospholipase A.sub.2 polypeptide
OF THE INVENTION The present invention provides a novel intracellular human phospholipase A.sub.2 ...


 DNA encoding Bcl-2-associated proteins
The present invention relates to a nucleic acid molecule encoding a protein or a fragment thereof ...


 Hybridoma-producing NSO myeloma cell line
This invention is directed to NSO.sup.bcl-2 myeloma cells and to methods of producing said cells. T...


 Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
OF THE PREFERRED EMBODIMENTS The present invention provides an improved method for the ...


 Bax inhibitor proteins
The present invention provides substantially purified nucleic acid molecules encoding Bax inhibitor ...


 Phosphonomonoester nucleic acids, process for their preparation, and their use
What is claimed is: 1. A compound of formula I ##STR37## in which n is a number from zero to 100; A ...


 L-654,040, antibacterial agent

Details
Inventors: Currie, Sara A.; Miller, Thomas W.; Dulaney, Eugene L.; Springer, James P.; Valiant, Mary E.; Mochales del Val, Sagrario; Zimmerman, Sheldon B.;
Assignee: Merck & Co., Inc. (Rahway, NJ)
Primary Examiner: Bond; Robert T.
Assistant Examiner:
Attorney, Agent or Firm: Daniel; Mark R., Caruso; Charles M.

L-654,040 of the structure: ##STR1## is a novel antibacterial and isolated from the novel organism Streptoverticillium synroense, strain MA6011, deposited at the ATCC.

DETAILED DESCRIPTION OF THE INVENTION Antibacterial L-654,040 is obtained by growing under controlled conditions the microorganism Streptoverticillium synroense MA6011, ATCC 53699 in a fermentation broth.
The fermentation may be carried out in media containing suspended nutrient matter or in predominantly clear media wherein the medium is substantially free of suspended nutrient matter.
Based on extensive taxonomic studies, the antibiotic producing microorganism is identified as the new species Streptoverticillium synroense.
A useful strain is designated MA6011 in the culture collection of MERCK & CO.
, Inc.
, Rahway, N.
J.
On or about Dec.
10, 1987, a culture thereof has been placed on permanent deposit with the culture collection of the American Type Culture Collection, 12301 Parklawn Drive, Rockville, Md.
20852, and has been assigned Accession No.
ATCC 53699.
MORPHOLOGICAL AND CULTURAL CHARACTERISTICS OF STREPTOVERTICILLIIUM SYNROENSE MA6011, ATCC 53699 The morphological and cultural characteristics of Streptoverticillium synroense MA6011, ATCC 53699 are set forth below.
Morphology Using standard media and procedures, morphological and cultural characteristics of the producing organism were examined according to Bergey, Manual of Determinative Bacteriology, 8th Edition, Williams & Wilkins.
Based on comparison with the published description of other species of the genus Streptoverticillium, it was determined that the producing organism is a new strain of a new species, identified in the Merck collection as Streptoverticillium synroense, strain MA6011.
CULTURAL CHARACTERISTICS OF STREPTOVERTICILLIUM SYNROENSE MA-6011, PRODUCING ORGANISM OF L-654,040 A.
Morphology Sporophores form short branches produced in a verticil or whorl at intervals along the aerial mycelia.
These branches in turn produce several secondary branches that form straight chains of 10-15 spores.
Spore surface appears rough, almost warty at high magnifications (EM).
Yeast Extract-Malt Extract Agar (ISP Medium 2) V.
sup.
1 : Reverse - black A: Mixed light and medium gray SP: Very dark brown



Related patents
  Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
The invention provides compounds including peptides and peptidomimetics that inhibit cell proliferation. The invention compounds are therefore useful for treating cell ...
  Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
The present invention includes a process of transfecting a polynucleotide into a cell for expression by associating a selected cell with an amphipathic compound, an ...
  Compositions for the introduction of polyanionic materials into cells
The present invention provides compositions and methods which are useful for the introduction of polyanionic materials into cells. The compositions are mixtures of ...
  Highly packed polycationic ammonium, sulfonium and phosphonium lipids
OF THE INVENTION The present invention provides novel, highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds having unique properties and ...
  Method for the liposomal delivery of nucleic acids
The present invention relates to a nucleic acid-liposome preparation, useful in delivery of nucleic acid-based materials to cells. The present invention further relates ...
  Highly packed polycationic ammonium, sulfonium and phosphonium lipids
OF THE INVENTION The present invention provides novel, highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds having unique properties and ...
  N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
According to a first aspect of the invention, the compounds of this invention are illustrated by Formula (I): ##STR2## or an optical isomer thereof, wherein R.sup.1 and R...
  Low stress conformal coatings of reliability without hermeticity for microelectromechanical system based multichip module encapsulation
The present invention overcomes the limitations of existing technology and addresses the needs therein by providing low stress conformal coatings. In one aspect of the ...
  Nucleic acids encoding JTT-1 protein
What is claimed is: 1. An isolated nucleic acid comprising a nucleotide sequence that encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:2. 2. The ...
  Nucleic acids encoding calcitonin receptor and uses thereof
The Drawings The drawings are first described. FIGS. 1A and 1B are a composite of graphs depicting binding of porcine calcitonin to cells. FIG. 1A) Porcine calcitonin ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved